|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 701 Pennsylvania Ave., NW |
Address2 | Suite 700 |
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 308456-12
|
||||||||
|
6. House ID# 396000000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Tracey A. Moorhead, President & CEO |
Date | 07/17/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Education and support for population-based health programs, including disease and care management in FFS Medicare and Medicare Advantage, including Special Needs Plans (specifically the reauthorization of Chronic Care Special Needs Plans, or C-SNPs and the incorporation of reasonable process measures and standards for SNP evaluation); Medicare pilots including Medicare Health Support (as authorized under Section 721 of the Medicare Prescription Drug, Improvement and Modernization Act (MMA), which created the
"Voluntary Chronic Care Improvement Program," now called Medicare Health Support (MHS)); and Medicare demonstrations, including the Medicare Coordinated Care Demonstration (MCCD, as authorized under Section 4016 of the Balanced Budget Act of 1997), and the Senior Risk Reduction Demonstration (SRRD). Provision of comments on CMS proposed and developed evaluations of care and disease management programs in Medicare Advantage. Advocacy for population health improvement as a tool to improve the quality of health care and health care outcomes, and reduce preventable health care costs. Encouragement of efforts to preserve HIPAA provisions permitting exchange of protected health information for care coordination and disease management, efforts to advance HIT deployment, particularly as it would effect individuals with chronic conditions, including e-prescribing, and the creation of interoperability standards and priority use cases and best practices for technologies that merge classical medical devices and telecommunications (American Health Information Community Chronic Care Workgroup initiatives). Education regarding effectiveness of chronic condition care and its benefits to Medicaid and other populations via the sharing of published quality improvement studies that reported cost or utilization outcomes from the intervention and which are target clinical conditions relevant for Medicaid programs. Advocacy around the CMS Medical Home Demonstration; S. 631 & H.R. 5765, the Remote Monitoring Access Act of 2007; S. 334, the Healthy Americans Act; S. 1340, the Geriatric
Assessment and Chronic Care Coordination Act of 2007; S. 1753, the Health Workforce Act of 2007; H.R. 3800, the Wired for Healthcare Quality Act and discussion drafts of HIT & privacy legislation; H.R. 5442, TRUST in Health Information Act of 2008; S. 3101, Medicare Improvements for Patients and Providers Act of 2008; S. 3118, Preserving Access to Medicare Act of 2008; H.R. 853, Wellness and Prevention Act of 2007; H.R.6331, Medicare Improvements for Patients and Providers Act of 2008 and the broader inclusion of coordinated care stakeholder expertise in studies and proposals around a Medicare chronic care practice research network; initiatives pertaining to the treatment and prevention of obesity as a chronic disease generally and specifically as related to Medicare Part D coverage of pharmacotherapy as a component of population health improvement approaches to addressing the obesity epidemic.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracey |
Moorhead |
|
|
|
Jennifer |
Martin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |